S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
LON:PRM

Proteome Sciences (PRM) Share Price, News & Analysis

GBX 3.39
+0.09 (+2.73%)
(As of 03/28/2024 ET)
Today's Range
3.12
3.39
50-Day Range
3.02
5.28
52-Week Range
3
8.79
Volume
16,418 shs
Average Volume
117,096 shs
Market Capitalization
£10.01 million
P/E Ratio
418.00
Dividend Yield
6.17%
Price Target
N/A
PRM stock logo

About Proteome Sciences Stock (LON:PRM)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

PRM Stock Price History

PRM Stock News Headlines

Proteome Sciences (LON:PRM) Sets New 1-Year Low at $3.00
Buy Friday, Sell Monday, No Exceptions
Every week traders grind it out Monday through Friday… But neglect trading Friday to Monday… Or… “over the weekend” As one professional trader explains, trading over the weekend is one of the most forgiving strategies you can use today. It allows him to sidestep a lot of the midweek volatility. Yet, gives him the opportunity to target some of the markets biggest stock moves. Just recently, he posted a trade on Nordstrom… The trade was published at 3pm on a Friday afternoon and by Monday morning the trade more than doubled.
Proteome Sciences PLC (PRM.AQ)
Proteome Sciences opens lab in San Diego
Proteome Sciences opens lab in San Diego’s biotech hub
$25,000 into $109,616 in two months?
Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…
Proteome Sciences
See More Headlines
Receive PRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2020
Today
3/28/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Net Income
£1.32 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£7.75 million
Cash Flow
GBX 0.84 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.22 million
Optionable
Not Optionable
Beta
-0.03
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Mariola Sohngen (Age 63)
    CEO & Executive Director
    Comp: $310k
  • Mr. Abdelghani Omari (Age 47)
    CFO & Director
    Comp: $209k
  • Dr. Ian H. Pike (Age 60)
    Chief Scientific Officer & Executive Director
    Comp: $233k
  • Mr. Richard Paul Dennis (Age 65)
    Chief Commercial Officer & Executive Director
    Comp: $235k
  • Mr. Glenn Barney
    Vice President of Sales & Marketing
  • Victoria Joanna Birse
    Company Secretary

PRM Stock Analysis - Frequently Asked Questions

How have PRM shares performed in 2024?

Proteome Sciences' stock was trading at GBX 4.53 at the beginning of 2024. Since then, PRM shares have decreased by 31.0% and is now trading at GBX 3.13.
View the best growth stocks for 2024 here
.

How were Proteome Sciences' earnings last quarter?

Proteome Sciences plc (LON:PRM) announced its earnings results on Monday, August, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Proteome Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK).

How do I buy shares of Proteome Sciences?

Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:PRM) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners